Survival, quality-adjusted survival, and other clinical end points in older advanced non-small-cell lung cancer patients treated with albumin-bound paclitaxel

BACKGROUND: This analysis compared the quality-adjusted survival and clinical outcomes of albumin-bound paclitaxel+carboplatin (nab-PC) vs solvent-based paclitaxel+carboplatin (sb-PC) as first-line therapy in advanced non-small-cell lung cancer (NSCLC) in older patients. METHODS: Using age-based sub...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Br J Cancer
मुख्य लेखकों: Langer, C J, Hirsh, V, Okamoto, I, Lin, F-J, Wan, Y, Whiting, S, Ong, T J, Renschler, M F, Botteman, M F
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Nature Publishing Group 2015
विषय:
Clinical Studies
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4647528/
https://ncbi.nlm.nih.gov/pubmed/26035702
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.181
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन